Tuesday, October 02, 2018 11:07:50 AM
If checkpoint theory is revolutionary, and I do not doubt it, then:
1 - Why has not Eli Lilly bought out RGBP?
2 - If as RGBP's PR stated ("If our stuff pans out"); then what does Lilly know about NERF?
3 - With What Lilly does know, Why did they not make a major financial investment in Koos?
4 - Is Lilly's lack of RGBP investment interest telling this board that they have better candidates with better NERF's? Or does Lilly have it's own super secret NERF program?
IMO You could take a high risk flyer on RGBP, if their balance sheet justified it, track record justified it, and solid management. But, the reality is RGBP is insolvent and exists in Koosland = OTC Koosklomerate.
Bottom line, and indirect PR within same technology class is not investable.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM